Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8767127 | 0.87 | TSHR (0.39) | TSHRSMN1; SMN2 | |
| SCHEMBL3094424 | 0.78 | SMN1; SMN2 (0.54) | TSHRSMN1; SMN2 | |
| SCHEMBL312355 | 0.76 | SMN1; SMN2 (0.42) | TSHRSMN1; SMN2 | |
| SCHEMBL6432852 | 0.76 | TSHR (0.52) | TSHRSMN1; SMN2 | |
| SCHEMBL12965171 | 0.74 | SMN1; SMN2 (0.45) | TSHRSMN1; SMN2 | |
| SCHEMBL27733055 | 0.74 | TSHR (0.50) | TSHRSMN1; SMN2 | |
| SCHEMBL4437119 | 0.74 | TSHR (0.45) | TSHRSMN1; SMN2 | |
| Perfluorotoluene SCHEMBL308464 | 0.73 | SMN1; SMN2 (0.41) | TSHRSMN1; SMN2 | |
| Lithium SCHEMBL30525465 | 0.70 | TSHR (0.42) | TSHRSMN1; SMN2 | |
| SCHEMBL3168128 | 0.70 | SMN1; SMN2 (0.39) | TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0638064-B1 | SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER | BRITISH TECH GROUP (GB) | 1997-08-13 | — | — | EP | disclosed |
| US-5589500-A | TREATMENT OF TUMORS OR ANTICARCINOGENIC AGENTS | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1996-12-31 | — | — | US | disclosed |
| EP-0638064-A1 | SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER. | BRITISH TECH GROUP (GB) | 1995-02-15 | — | — | EP | disclosed |
| WO-1993022275-A1 | SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER | BRITISH TECHNOLOGY GROUP LTD (GB) | 1993-11-11 | — | — | WO | disclosed |